Extracorporeal Membrane Oxygenation System Market Size, Share, Trends & Analysis By Type, Regional Outlook, Industry Insights, Key Players, Applications And Forecast To 2028

  • Category:Pharmaceuticals & Healthcare
  • Published on:Mar 2021
  • Pages:115
  • Formats:
  • Report Code:32457

Report Summary

Eternity Insights has published a new study on Global Extracorporeal Membrane Oxygenation System Market focusing on key segments as by Type (Veno-Arterial (VA),Veno-Venous (VV),Arterio-Venous (AV), Other), by Application (Respiratory,Cardiac,Extracorporeal Cardiopulmonary Resuscitation (ECPR), Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Extracorporeal Membrane Oxygenation System Market.

The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.

Extracorporeal Membrane Oxygenation System Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Global Extracorporeal Membrane Oxygenation System Market Size, 2018-2028 (USD Million)

To learn more about this report

Request For Sample

Global Extracorporeal Membrane Oxygenation System Market Segmentation:

Extracorporeal Membrane Oxygenation System Market, By Type

  • Veno-Arterial (VA)
  • Veno-Venous (VV)
  • Arterio-Venous (AV)
  • Other

Extracorporeal Membrane Oxygenation System Market, By Application

  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)
  • Other

To learn more about this report

Request For Sample

Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Extracorporeal Membrane Oxygenation System market in terms of demand generation. The Extracorporeal Membrane Oxygenation System market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Extracorporeal Membrane Oxygenation System market for below listed coun-tries across each region.

North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).

Global Extracorporeal Membrane Oxygenation System Market Taxonomy:

To learn more about this report

Request For Sample

Global Extracorporeal Membrane Oxygenation System Market Competitive Landscape

The global Extracorporeal Membrane Oxygenation System market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details

  • Company Overview
  • Financial Analysis
  • Product Portfolio Analysis
  • Strategic Overview
  • SWOT Analysis

List of Companies Profiled in the report:

  • Getinge Group
  • Medtronic plc
  • LivaNova PLC
  • XENIOS AG
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • NIPRO Corporation
  • OriGen Biomedical
  • Inc.
  • ALung Technologies
  • Inc.
  • EUROSETS S.r.l.
  • Other Players of Specific Interest can be added based on requirement

Market Segmentation

Report Attributes Details
The market size value in 2021 USD XX.XX Million
CAGR (2021 - 2028) XX.XX %
The Revenue forecast in 2028 USD XX.XX Million
Base year for estimation 2021
Historical data 2018-2019
Forecast period 2022-2028
Quantitative units
  • Revenue in USD Million
  • CAGR from 2021 to 2028
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered By Type Outlook, Application Outlook, Regional Outlook
By Type Outlook Veno-Arterial (VA),Veno-Venous (VV),Arterio-Venous (AV), Other
By Application Outlook Respiratory,Cardiac,Extracorporeal Cardiopulmonary Resuscitation (ECPR), Other
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey
Key companies profiled Getinge Group,Medtronic plc,LivaNova PLC,XENIOS AG,Terumo Corporation,MicroPort Scientific Corporation,NIPRO Corporation,OriGen Biomedical, Inc.,ALung Technologies, Inc.,EUROSETS S.r.l.
Customization Available Yes, the report can be tailored to meet your specific requirements.

Key Benefits to the stake holders

  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come

Table Of Contents

Table of Contents

1 Study Coverage
1.1 Extracorporeal Membrane Oxygenation System Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Extracorporeal Membrane Oxygenation System Market Size Growth Rate by Product
1.4.2 Veno-Arterial (VA)
1.4.3 Veno-Venous (VV)
1.4.4 Arterio-Venous (AV)
1.5 Market by End User
1.5.1 Global Extracorporeal Membrane Oxygenation System Market Size Growth Rate by End User
1.5.2 Respiratory
1.5.3 Cardiac
1.5.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Extracorporeal Membrane Oxygenation System Market Size
2.1.1 Global Extracorporeal Membrane Oxygenation System Revenue 2014-2027
2.1.2 Global Extracorporeal Membrane Oxygenation System Sales 2014-2027
2.2 Extracorporeal Membrane Oxygenation System Growth Rate by Regions
2.2.1 Global Extracorporeal Membrane Oxygenation System Sales by Regions
2.2.2 Global Extracorporeal Membrane Oxygenation System Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Extracorporeal Membrane Oxygenation System Sales by Manufacturers
3.1.1 Extracorporeal Membrane Oxygenation System Sales by Manufacturers
3.1.2 Extracorporeal Membrane Oxygenation System Sales Market Share by Manufacturers
3.1.3 Global Extracorporeal Membrane Oxygenation System Market Concentration Ratio (CR5 and HHI)
3.2 Extracorporeal Membrane Oxygenation System Revenue by Manufacturers
3.2.1 Extracorporeal Membrane Oxygenation System Revenue by Manufacturers (2014-2019)
3.2.2 Extracorporeal Membrane Oxygenation System Revenue Share by Manufacturers (2014-2019)
3.3 Extracorporeal Membrane Oxygenation System Price by Manufacturers
3.4 Extracorporeal Membrane Oxygenation System Manufacturing Base Distribution, Product Types
3.4.1 Extracorporeal Membrane Oxygenation System Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Extracorporeal Membrane Oxygenation System Product Type
3.4.3 Date of International Manufacturers Enter into Extracorporeal Membrane Oxygenation System Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Extracorporeal Membrane Oxygenation System Sales by Product
4.2 Global Extracorporeal Membrane Oxygenation System Revenue by Product
4.3 Extracorporeal Membrane Oxygenation System Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Extracorporeal Membrane Oxygenation System Breakdown Data by End User

6 North America
6.1 North America Extracorporeal Membrane Oxygenation System by Countries
6.1.1 North America Extracorporeal Membrane Oxygenation System Sales by Countries
6.1.2 North America Extracorporeal Membrane Oxygenation System Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Extracorporeal Membrane Oxygenation System by Product
6.3 North America Extracorporeal Membrane Oxygenation System by End User

7 Europe
7.1 Europe Extracorporeal Membrane Oxygenation System by Countries
7.1.1 Europe Extracorporeal Membrane Oxygenation System Sales by Countries
7.1.2 Europe Extracorporeal Membrane Oxygenation System Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Extracorporeal Membrane Oxygenation System by Product
7.3 Europe Extracorporeal Membrane Oxygenation System by End User

8 Asia Pacific
8.1 Asia Pacific Extracorporeal Membrane Oxygenation System by Countries
8.1.1 Asia Pacific Extracorporeal Membrane Oxygenation System Sales by Countries
8.1.2 Asia Pacific Extracorporeal Membrane Oxygenation System Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Extracorporeal Membrane Oxygenation System by Product
8.3 Asia Pacific Extracorporeal Membrane Oxygenation System by End User

9 Central & South America
9.1 Central & South America Extracorporeal Membrane Oxygenation System by Countries
9.1.1 Central & South America Extracorporeal Membrane Oxygenation System Sales by Countries
9.1.2 Central & South America Extracorporeal Membrane Oxygenation System Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Extracorporeal Membrane Oxygenation System by Product
9.3 Central & South America Extracorporeal Membrane Oxygenation System by End User

10 Middle East and Africa
10.1 Middle East and Africa Extracorporeal Membrane Oxygenation System by Countries
10.1.1 Middle East and Africa Extracorporeal Membrane Oxygenation System Sales by Countries
10.1.2 Middle East and Africa Extracorporeal Membrane Oxygenation System Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Extracorporeal Membrane Oxygenation System by Product
10.3 Middle East and Africa Extracorporeal Membrane Oxygenation System by End User

11 Company Profiles
11.1 Getinge Group
11.1.1 Getinge Group Company Details
11.1.2 Company Business Overview
11.1.3 Getinge Group Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Getinge Group Extracorporeal Membrane Oxygenation System Products Offered
11.1.5 Getinge Group Recent Development
11.2 Medtronic plc
11.2.1 Medtronic plc Company Details
11.2.2 Company Business Overview
11.2.3 Medtronic plc Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Medtronic plc Extracorporeal Membrane Oxygenation System Products Offered
11.2.5 Medtronic plc Recent Development
11.3 LivaNova PLC
11.3.1 LivaNova PLC Company Details
11.3.2 Company Business Overview
11.3.3 LivaNova PLC Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2014-2019)
11.3.4 LivaNova PLC Extracorporeal Membrane Oxygenation System Products Offered
11.3.5 LivaNova PLC Recent Development
11.4 XENIOS AG
11.4.1 XENIOS AG Company Details
11.4.2 Company Business Overview
11.4.3 XENIOS AG Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2014-2019)
11.4.4 XENIOS AG Extracorporeal Membrane Oxygenation System Products Offered
11.4.5 XENIOS AG Recent Development
11.5 Terumo Corporation
11.5.1 Terumo Corporation Company Details
11.5.2 Company Business Overview
11.5.3 Terumo Corporation Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Terumo Corporation Extracorporeal Membrane Oxygenation System Products Offered
11.5.5 Terumo Corporation Recent Development
11.6 MicroPort Scientific Corporation
11.6.1 MicroPort Scientific Corporation Company Details
11.6.2 Company Business Overview
11.6.3 MicroPort Scientific Corporation Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2014-2019)
11.6.4 MicroPort Scientific Corporation Extracorporeal Membrane Oxygenation System Products Offered
11.6.5 MicroPort Scientific Corporation Recent Development
11.7 NIPRO Corporation
11.7.1 NIPRO Corporation Company Details
11.7.2 Company Business Overview
11.7.3 NIPRO Corporation Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2014-2019)
11.7.4 NIPRO Corporation Extracorporeal Membrane Oxygenation System Products Offered
11.7.5 NIPRO Corporation Recent Development
11.8 OriGen Biomedical, Inc.
11.8.1 OriGen Biomedical, Inc. Company Details
11.8.2 Company Business Overview
11.8.3 OriGen Biomedical, Inc. Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2014-2019)
11.8.4 OriGen Biomedical, Inc. Extracorporeal Membrane Oxygenation System Products Offered
11.8.5 OriGen Biomedical, Inc. Recent Development
11.9 ALung Technologies, Inc.
11.9.1 ALung Technologies, Inc. Company Details
11.9.2 Company Business Overview
11.9.3 ALung Technologies, Inc. Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2014-2019)
11.9.4 ALung Technologies, Inc. Extracorporeal Membrane Oxygenation System Products Offered
11.9.5 ALung Technologies, Inc. Recent Development
11.10 EUROSETS S.r.l.
11.10.1 EUROSETS S.r.l. Company Details
11.10.2 Company Business Overview
11.10.3 EUROSETS S.r.l. Extracorporeal Membrane Oxygenation System Sales, Revenue and Gross Margin (2014-2019)
11.10.4 EUROSETS S.r.l. Extracorporeal Membrane Oxygenation System Products Offered
11.10.5 EUROSETS S.r.l. Recent Development

12 Future Forecast
12.1 Extracorporeal Membrane Oxygenation System Market Forecast by Regions
12.1.1 Global Extracorporeal Membrane Oxygenation System Sales Forecast by Regions 2019-2025
12.1.2 Global Extracorporeal Membrane Oxygenation System Revenue Forecast by Regions 2019-2025
12.2 Extracorporeal Membrane Oxygenation System Market Forecast by Product
12.2.1 Global Extracorporeal Membrane Oxygenation System Sales Forecast by Product 2019-2025
12.2.2 Global Extracorporeal Membrane Oxygenation System Revenue Forecast by Product 2019-2025
12.3 Extracorporeal Membrane Oxygenation System Market Forecast by End User
12.4 North America Extracorporeal Membrane Oxygenation System Forecast
12.5 Europe Extracorporeal Membrane Oxygenation System Forecast
12.6 Asia Pacific Extracorporeal Membrane Oxygenation System Forecast
12.7 Central & South America Extracorporeal Membrane Oxygenation System Forecast
12.8 Middle East and Africa Extracorporeal Membrane Oxygenation System Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Extracorporeal Membrane Oxygenation System Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Choose License Type

close

categories